About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

Cyclops®

Convenient
Reliable
Easy-to-use
Easy-to-carry
Hygienic
Less Cough

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

Jaap Wieling will present Epinephrine Cyclops® on GAFA

Please check out our latest poster on Epinephrine Cyclops® for GAFA 2025!

GAFA 2025 is a medical conference on food allergy and anaphylaxis in Padua, Italy from 11–13 September 2025 and Jaap Wieling will attend this conference.

Interested? Contact Jaap (jwieling@pureims.com)!

SHARE THIS POST

Join a great team in advancing inhalation innovation!

Colistin Cyclops® Gains EMA and FDA Orphan Drug Status in Cystic Fibrosis

CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS

International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®

Cyclops® in Inhalation Technology magazine!

PureIMS gears up for abbreviated registration of Levodopa Cyclops® against OFF episodes in Parkinson’s disease with the successful completion of a comparative pharmacokinetic study

PureIMS winning the LIFE Science Innovation Award!

PureIMS initiates dose-finding study with Levodopa Cyclops™ dry powder inhaler

PureIMS secures new investment round to develop lead inhalation product and facilitate partnering activities

Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™

Contact Us

Ceintuurbaan Noord 152
9301 NZ Roden
The Netherlands
T: +31 (0)50 – 2053 325
F: +31 (0)50 – 2053 326
E: info@pureims.com

Social media

Linkedin-in Youtube

Inspiration by Patients

CALL US NOW